Philip J. Landrigan, M.D., and Charles Benbrook, Ph.D. N Engl J Med 2015; 373:693-695August 20, 2015DOI: 10.1056/NEJMp1505660 Genetically modified organisms (GMOs) are not high on most physicians’ worry lists. If we think at all about biotechnology, most of us probably focus on direct threats to human health, such as prospects for converting pathogens to biologic […]